Skip to main content

High Doses of ADHD Meds Could Trigger Psychosis

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 12, 2024.

By Dennis Thompson HealthDay Reporter

THURSDAY, Sept. 12, 2024 -- Prescriptions for amphetamine stimulants to treat ADHD have increased significantly in recent years, particularly during the pandemic.

Unfortunately, high doses of stimulants like Adderall can increase the risk of psychosis or mania by more than fivefold, a new study finds.

Patients had a nearly 63% increased risk of psychosis or mania if they took any prescription amphetamine within the past month, researchers reported Sept. 12 in the American Journal of Psychiatry.

Those on heavy doses of amphetamines were at even greater peril of a psychotic episode, with an 81% increased risk, results show.

The highest risk occurred in patients taking 30 milligrams or more of dextroamphetamine, which corresponds to 40 milligrams of Adderall, the study says.

“Stimulant medications don’t have an upper dose limit on their labels, and our results show that it is clear that dose is a factor in psychosis risk and should be a chief consideration when prescribing stimulants,” said lead investigator Dr. Lauren Moran, a pharmacoepidemiology researcher at McLean Hospital in Belmont, Mass.

“This is a rare but serious side effect that should be monitored by both patients and their doctors whenever these medications are prescribed,” Moran added.

Moran said she pursued this study based on her experiences as an inpatient psychiatrist.

She and her Mclean colleagues would regularly see patients experiencing their first episode of psychosis. Medical records would reveal the patients had been prescribed high doses of stimulants by their doctors.

For the study, researchers analyzed data on nearly 1,400 patients admitted to Mass General Brigham Hospital between 2005 and 2019 who were in the throes of their first episode of psychosis or mania.

They compared those patients against more than 2,700 people hospitalized for other psychiatric conditions like depression or anxiety.

They found that people taking amphetamines had a higher risk of psychosis and mania, and that the risk was greatest with heavy doses.

This link could be explained by the fact that amphetamines prompt the release of dopamine, a brain hormone also implicated in psychosis, researchers said.

People taking amphetamines for ADHD shouldn’t be alarmed, Moran said, but they might want to talk with their doctor about the dosage they’ve been prescribed.

There also are alternative drugs to treat ADHD that don’t increase mental health risk.

For example, this study found no increased risk of psychosis or mania in prescriptions for methylphenidate (Ritalin), Moran noted.

“There’s limited evidence that prescription amphetamines are more effective in high doses,” Moran said in a Mass General Brigham news release. “Physicians should consider other medications our study found to be less risky, especially if a patient is at high risk for psychosis or mania.”

Sources

  • Mass General Brigham, news release, Sept. 12, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Amid Shortages, U.S. Allows Expanded Production of ADHD Drug Vyvanse

THURSDAY, Sept. 5, 2024 -- The maker of the ADHD drug Vyvanse has been given approval by the U.S. Drug Enforcement Administration to make more of the medication as a shortage of...

Parents' Excessive Smartphone Use Could Harm Children's Mental Health

FRIDAY, Aug. 16, 2024 -- A child at the dinner table talks about trouble at school or an argument with a friend, but parents aren't listening: They're checking their smartphones...

Not Born Equal: Preemie Babies Fall Into 3 Risk Categories

WEDNESDAY, Aug. 14, 2024 -- Not all babies born prematurely will suffer long-term developmental problems, a new study finds. Preemies tend to fall into three risk categories...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.